McKesson Corporation dba McKesson Drug Company recalls Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Sout…

Recall date

May 26, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0630-2021

FDA classification

Class III

Brand / firm

McKesson Corporation dba McKesson Drug Company

Sold / distributed

Nationwide in the US

Why it was recalled

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10